申请人:Pelcman Benjamin
公开号:US20100004301A1
公开(公告)日:2010-01-07
There is provided the use of a compound of formula I,
wherein Y, W
1
to W
4
, Z
1
to Z
4
and R have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a disease in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
本发明提供了一种化合物I的应用,其中Y、W1至W4、Z1至Z4和R的含义如说明书中所述,并且其药学上可接受的盐,用于制备治疗需要或期望抑制MAPEG家族成员活性的疾病的药物,特别是用于治疗炎症。